Xeomin

Xeomin is a purified botulinum toxin type A used for temporary muscle relaxation. It is free of complexing proteins and administered by healthcare professionals. Commonly used for cosmetic and therapeutic applications. Suitable for adults seeking targeted treatment options.

Xeomin is used to temporarily reduce the appearance of moderate to severe frown lines between the eyebrows. It is also employed for the treatment of cervical dystonia, blepharospasm, and upper limb spasticity. Healthcare providers may recommend it for other off-label uses based on individual needs. This neurotoxin works by blocking nerve signals to targeted muscles.

After administration, Xeomin typically begins to take effect within a few days, with full results visible in about two weeks. The effects are temporary and usually last between three to six months, depending on the treated area and individual response. Some users may experience mild discomfort or swelling at the injection site.

Xeomin should only be administered by a qualified healthcare professional experienced in the use of botulinum toxin. Inform your provider of any allergies, medical conditions, or medications you are taking. Avoid rubbing or massaging the treated area for at least 24 hours post-injection to prevent spreading the toxin. Keep follow-up appointments to monitor results.

Xeomin may interact with medications that affect neuromuscular transmission, such as aminoglycoside antibiotics or muscle relaxants. Alcohol and other substances that may increase bleeding risk should be avoided before and after treatment. Always disclose all medications and supplements to your healthcare provider to assess potential interactions.